Trial Library operates an AI-enabled platform that connects biopharmaceutical manufacturers, payers, health systems, providers and patients to clinical trials offered as a standard care option. The technology activates community-based clinicians, identifies eligible patients compliantly, and guides them through the entire trial lifecycle. The company already supports more than 320 clinics and 1,500 providers nationwide, demonstrating meaningful early network scale. Led by founder and CEO Dr. Hala Borno, Trial Library positions itself as an accelerator of precision medicine uptake, working closely with self-insured and traditional health plans. Fresh capital is earmarked to deepen product development and broaden operational reach, enabling further clinic onboarding and payer partnerships. To date, the company has secured a total of $15 million in venture financing, underlining growing investor confidence in its model.

Total raised

$15M

Funding rounds

2

Latest round

Series A

Latest activity

Dec 2025